Aradigm corp (ARDM)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-

-3,802

-4,802

-

-

1,035

-3,678

-7,937

-8,186

-8,729

-8,086

-1,163

-831

-914

-1,358

7,755

-655

-14,874

-2,710

-3,325

-2,543

-1,962

-1,761

-1,960

-1,519

-2,449

-2,894

-2,447

Adjustments to reconcile net loss to cash used in operating activities:
Amortization and accretion of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

-9

-19

0

2

-3

-13

-

-

-

-

Depreciation and amortization

33

33

34

33

30

27

28

31

33

28

29

77

80

82

74

74

93

92

92

93

94

97

99

101

102

103

113

127

Stock-based compensation expense

258

409

547

719

736

620

543

491

385

400

400

185

144

134

145

193

83

134

109

95

89

105

148

131

-79

234

190

188

Amortization of convertible debt discount

465

451

483

470

453

441

424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,823

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,041

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of convertible debt discount

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

19

27

25

22

20

18

15

14

12

-

-

-

-

Changes in operating assets and liabilities:
Cost of warrants and options for service

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

Receivables

38

-103

-17

-163

23

21

152

127

-290

-37

217

-547

967

-977

-1,625

2,601

-13,021

13,052

17

1

-17

5

4

13

-15

-46

22

-105

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

250

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

-210

-87

320

-241

9

-520

104

-401

-894

-1,337

35

235

235

-3

-306

-167

177

1,051

25

89

-101

-5

-18

69

-216

-65

267

-5

Other assets

-

-

0

-

-

-

0

-

-

-

-

-15

-10

6

2,870

-26

-35

-31

-29

-26

-23

-20

-19

-45

-42

-15

471

-1

Accounts payable

-183

-439

-69

-76

-78

526

-179

-67

-373

-1,382

744

-660

1,274

-2,547

2,413

947

47

-226

594

-126

-74

210

11

-13

20

-35

21

-67

Accrued compensation

162

-14

-1,030

-102

596

337

-79

-8

322

331

-469

-269

-14

-129

523

241

-368

269

52

61

-74

-34

42

55

-151

-370

398

-9

Accrued clinical and cost of other studies, non-current

-

-

-

-

-

-

-

-

-

-

-

-49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6

6

5

6

11

11

Deferred revenue - related party

-

-

-

6,647

2,329

-7,452

-1,524

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current deferred revenue - related party

-

-

-1,344

-

-

-

-

-

-

-

-

-47

382

-734

253

3,688

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-1,249

2,039

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

557

62

701

-

493

-2,173

-656

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

259

-235

1,510

-15

-59

278

283

117

8

58

-701

-624

634

-344

Deferred Rent

-

7

11

-

-

-

-

0

0

-18

-19

-12

-11

-12

-6

-6

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,097

-1,471

-1,423

-1,660

-2,087

-2,963

-2,271

-2,449

Cash flows from investing activities:
Facility lease exit obligation

-

-

-

-

-

-

-

0

-4

-51

-49

-43

-43

-50

-38

-37

-36

-43

-32

-32

-31

-37

-26

-26

-25

-31

-22

-21

Net cash used in operating activities

-

-

-5,772

-

-

-

-5,377

-6,734

-5,150

-7,645

-8,951

577

-591

-1,679

8,636

-6,259

9,183

-4,002

-1,936

-2,981

-

-

-

-

-

-

-

-

Capital expenditures

0

0

1

-

-

-

-

6

29

0

40

-

0

125

120

167

32

4

6

1

-

-

-

-

0

0

0

5

Capital expenditures

-

-

-

-

-

-

-

-

-

-

-

-9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

230

113

2,509

203

499

1,150

650

399

7,806

899

250

Proceeds from maturities of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

230

1,010

1,583

203

1,000

1,295

4,390

2,115

-

-

-

-

Net cash used in investing activities

-

-

-1

-

-

-

-

1,004

-245

-1,800

-40

9

0

-125

-120

-167

198

776

1,464

-2,307

-

-

-

-

-

-

-

-

Payments of convertible notes and warrants issuance costs

-

-

-

-

-

-

-

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

797

791

3,240

1,465

2,121

-7,806

-399

-255

Cash flows from financing activities:
Net cash provided by financing activities

-

-

73

-

-

-

-

-178

2,681

18,237

-50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

18

4

73

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

704

-5,700

-

-

-5,186

-5,377

-5,908

-2,714

8,792

-9,041

586

-502

-1,798

8,585

-6,426

9,438

37,000

-433

-5,288

4,286

-680

1,855

-195

74

-6,407

5,890

-2,704

Supplemental disclosure of non-cash activities:
Deferred issuance costs for planned convertible notes and warrants in accrued expenses

-

-

-

-

-

-

-

-

-

-

83

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cumulative effect of adoption of new accounting standards

-

-

-

0

0

0

6,046

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued in payment of officer bonus

-

-

-

0

0

0

444

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash reduction in other assets from extinguishment of debt and assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-237

-

-

-

-

-

-

-

-

-

-

-

-

Non cash reduction in note payable from extinguishment of debt and assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

9,101

-

-

-

-

-

-

-

-

-

-

-

-